Claims
- 1. A method comprising crystallizing 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane from a solution comprising at least one organic solvent and at least one nitrate ester non-solvent.
- 2. The method of claim 1, wherein the nitrate ester non-solvent comprises at least one member selected from the group consisting of poly(glycidyl nitrate) and triethyleneglycol-dinitrate.
- 3. A method of crystallizing 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane, comprising:combining 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane, at least one organic solvent present in an effective amount to completely dissolve the 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane into solution, and at least one nitrate ester non-solvent which is miscible with the solvent to form a solution; saturating the solution; adding 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane crystalline seeds to the saturated solution; evaporating the solvent from the saturated solution while simultaneously growing 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane crystals from the saturated solution onto the crystalline seeds; and separating the nitrate ester non-solvent and non-evaporated remnants, if any, of the solvent from the crystals.
- 4. The method of claim 3, wherein the nitrate ester non-solvent comprises poly(glycidyl nitrate).
- 5. The method of claim 3, wherein the nitrate ester non-solvent comprises triethyleneglycol-dinitrate.
- 6. The method of claim 3, wherein the nitrate ester non-solvent comprises at least one member selected from the group consisting of butanetrioltrinitrate and diglycerol tetranitrate.
- 7. The method of claim 3, wherein the solvent comprises at least one alkyl acetate.
- 8. The method of claim 7, wherein the alkyl acetate comprises ethyl acetate.
- 9. The method of claim 3, wherein the solvent comprises at least one member selected from the group consisting of a ketone, a cyclic ether, nitromethane, and acetonitrile.
- 10. The method of claim 3, wherein said combining and said saturating of the solution are performed simultaneous by dissolving 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane into the CL-20 solvent and then adding an effective amount of the nitrate-ester non-solvent to form the saturated solution.
- 11. The method of claim 3, wherein said saturating of the solution comprises evaporating off the CL-20 solvent until the saturated solution is formed.
- 12. The method of claim 3, wherein said saturating of the solution comprises adding the 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane crystalline seeds to the solution until the solution is saturated.
- 13. The method of claim 3, wherein said evaporating of the solvent is conducted in a temperature range of from about 25° C. to about 60° C.
- 14. The method of claim 3, wherein a weight ratio of the nitrate ester non-solvent to CL-20 is in a range of from about 5:1 to about 8:1.
- 15. A method of crystallizing 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane comprising:combining 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane, at least one organic solvent present in an effective amount to completely dissolve the 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane into solution, and at least one nitrate ester non-solvent which is miscible with the solvent to form a solution, the nitrate ester non-solvent comprising at least one member selected from the group consisting of poly(glycidyl nitrate) and triethylene glycol dinitrate; saturating the solution; adding 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane crystalline seeds to the saturated solution; evaporating the solvent from the saturated solution while simultaneously growing 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane crystals from the saturated solution onto the crystalline seeds; and separating the nitrate ester non-solvent and non-evaporated remnants, if any, of the solvent from the crystals.
- 16. The method of claim 15, wherein the nitrate ester non-solvent further comprises at least one member selected from the group consisting of butanetrioltrinitrate and diglycerol tetranitrate.
- 17. The method of claim 15, wherein the solvent comprises at least one alkyl acetate.
- 18. The method of claim 17, wherein the alkyl acetate comprise ethyl acetate.
- 19. The method of claim 15, wherein the solvent comprises at least one member selected from the group consisting of a ketone, a cyclic ether, nitromethane, and acetonitrile.
- 20. The method of claim 15, wherein said combining and said saturating of the solution are performed simultaneous by dissolving 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane into the CL-20 solvent and then adding an effective amount of the nitrate ester non-solvent to form the saturated solution.
- 21. The method of claim 15, wherein said saturating of the solution comprises evaporating off the CL-20 solvent until the saturated solution is formed.
- 22. The method of claim 15, wherein said saturating of the solution comprises adding the 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane crystalline seeds to the solution until the solution is saturated.
- 23. The method of claim 15, wherein said evaporating of the solvent is conducted in a temperature range of from about 25° C. to about 60° C.
- 24. The method of claim 15, wherein a weight ratio of the nitrate ester non-solvent to CL-20 is in a range of from about 5:1 to about 8:1.
- 25. A method of crystallizing 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane, comprising:combining 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane, at least one organic solvent present in an effective amount to completely dissolve the 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane into solution, and at least one nitrate ester non-solvent which is miscible with the solvent to form a solution; supersaturating the solution and holding the supersaturated solution until crystal growth commences by self-nucleation; evaporating the solvent from the supersaturated solution while simultaneously growing 2,4,6,8,10,12-hexanitro-2,4,6,8,10,12-hexaazatetracyclo[5.5.0.05,903,11]-dodecane crystals from the supersaturated solution onto the crystalline seeds; and separating the nitrate ester non-solvent and non-evaporated remnants, if any, of the solvent from the crystals.
- 26. The method of claim 25, wherein the nitrate ester non-solvent comprises at least one member selected from the group consisting of poly(glycidyl nitrate) and triethyleneglycol-dinitrate.
CROSS-REFERENCE TO RELATED APPLICATION
The benefit of priority of claimed of U.S. Provisional Application No. 60/193,468 filed in the U.S. Patent & Trademark Office on Mar. 31, 2000, the complete disclosure of which is incorporated herein by reference.
GOVERNMENT LICENSING CLAUSE
The U.S. Government has a paid-up license in this invention and the right in limited circumstances to require the patent owner to license others on reasonable terms as provided for by the terms of contract N00174-99-C-0030 awarded by the Indian Head Division of the Naval Air Warfare Center (NAWC).
US Referenced Citations (10)
Foreign Referenced Citations (1)
Number |
Date |
Country |
0 913 374 |
May 1999 |
EP |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/193468 |
Mar 2000 |
US |